Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -32.3% | n/a |
ROCE | 133.9% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.4 | n/a |
Pr/Book | 0.4 |
Latest | F'cast | |
---|---|---|
Revenue | -7.8% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-19 | n/a | (0.47) | (2.20)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-20 | n/a | (1.24) | (4.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 0.45 | (1.95) | (0.03)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 0.99 | (0.87) | (1.15)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 0.92 | (0.47) | (0.86)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Corporate Update | 04-Apr-2025 | 07:00 | RNS |
Corporate Update | 26-Mar-2025 | 07:00 | RNS |
Management Change | 17-Jan-2025 | 07:00 | RNS |
Actavis buys speciality drugmaker Forest Labs fo... | 19-Feb-2014 | Guardian |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.50p |
Change Today | 0.20p |
% Change | 15.38 % |
52 Week High | 4.00 |
52 Week Low | 1.30 |
Volume | 1,014,265 |
Shares Issued | 95.40m |
Market Cap | £1.43m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
12:45 | 100,000 @ 1.49p |
12:45 | 50,000 @ 1.49p |
11:04 | 592,321 @ 1.69p |
10:12 | 10,000 @ 1.50p |
09:56 | 33,810 @ 1.47p |
You are here: research